mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.0005 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.44 |
0.0006 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |